三苯基乙酸
三苯基乙酸结构式
|
常用名 | 三苯基乙酸 | 英文名 | Triphenylacetate |
|---|---|---|---|---|
| CAS号 | 595-91-5 | 分子量 | 287.332 | |
| 密度 | N/A | 沸点 | 401.4±12.0 °C at 760 mmHg | |
| 分子式 | C20H16O2 | 熔点 | 270-273 °C(lit.) | |
| MSDS | 中文版 美版 | 闪点 | 210.7±16.1 °C |
|
'Organic phase buffers' control biocatalyst activity independent of initial aqueous pH.
Biochim. Biophys. Acta 1206(2) , 161-5, (1994) Combinations of triisooctylamine with its hydrochloride, or of triphenylacetic acid with its Na+ salt, can function as buffers for use during biocatalysis in organic media. They can control the pH of an adjacent aqueous phase, even though both forms of each b... |
|
|
Inhibition of bilirubin UDPglucuronosyltransferase activity by triphenylacetic acid and related compounds.
Biochim. Biophys. Acta 883(2) , 190-6, (1986) Bilirubin UDPglucuronosyltransferase of rat or human liver microsomes was inhibited, in vitro, by triphenylacetic acid and by structurally related arylcarboxylic acids. This inhibition appeared to be competitive towards bilirubin, and mixed-type towards UDPgl... |
|
|
Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
J. Med. Chem. 51 , 976-82, (2008) Sickle cell disease (SCD) is a hereditary condition characterized by deformation of red blood cells (RBCs). This phenomenon is due to the presence of abnormal hemoglobin that polymerizes upon deoxygenation. This effect is exacerbated when dehydrated RBCs expe... |